increased bleeding under skin flaps and can expose the subject to an increased risk of pulmonary aspiration of vomitus if airway reflexes are depressed from the residual effects of anaesthetic and analgesic drugs.
The incidence and severity of PONV has been decreasing over the last 10 years, due to the identification of precipitating factors, the use of better anaesthetics and preoperative medications, and improvement in operative techniques. 3 Despite these changes, there is still an unacceptable frequency of PONV with incidences of up to 85% reported in some studies. 4 Watcha & White suggested that the incidence of PONV has remained fairly constant for decades with 20-30% of patients suffering from these unpleasant side-effects. 5 Many drugs have so far been tried to prevent or alleviate this problem. The antiemetics that are currently being used for treatment in our country are prochlorperazine, metoclopramide and promethazine. Antiemetic such as metoclopramide is often used in the control of PONV. It acts peripherally as a cholinomimetic and centrally as a dopaminergic antagonist by enhancing the stimulatory effects of acetylcholine on intestinal smooth muscle, metoclopramide increase lower esophageal sphincter tone, speeds gastric empting, and lowers gastric fluid volume. It also produces an antiemetic effect by blocking dopaminergic receptors in the chemoreceptor trigger zone of the central nervous system. But most of the drugs are associated with undesirable side effects including sedation, hypotension, extrapyramidal symptoms, dysphoria, nervousness and may also cause delayed recovery from anaesthesia. 6 Ondansetron is a selective competitive 5-HT 3 receptor antagonist with little or no effect on dopaminergic receptors. 7, 8 . It has a good safety profile. It does not appear to cause sedation, extrapyramidal signs or respiratory depression. The most common reported side effect is headache. 9 Antiemetic prophylaxis may be justified in patients who are at greater risk of developing postoperative nausea and /or vomiting 5 these include patients with a history of previous postoperative emesis, in day case surgical patient and women undergoing gynaecological procedure especially by laparoscopy.
In this study, we have investigated the efficacy of oral ondansetron to prevent PONV in diagnostic laparoscopy assisted gynaecological surgery and to compare it with oral metoclopramide.
Materials and Methods
Fifty female patients of ASA physical status I and II, age between 18-30 years and body weight between 50-60 kg, scheduled to undergo diagnostic laparoscopy assisted gynecological surgery under general anaesthesia were studied. The study protocol was approved by institutional ethical committee of Bangabandhu Sheikh Mujib Medical University (BSMMU). Informed written consent was taken from the patient. They were randomly divided into two groups, twenty five patients in each. The randomization was done by blind envelop methods. Patients with persisting vomiting, received any antiemetic within 24 hours before surgery, expected to have a nasogastric tube after surgery, renal, hepatic, cardiovascular, metabolic or endocrine dysfunction, history of motion sickness.
Patients belonging to Group-A patient were received Tab Metoclopramide 10mg orally an hour before operation and Group-B were received Tab ondansetron (0.15 mg/kg) or 8 mg orally an hour before operation, On arrival of the patients in the operation theatre IV line was inserted and pulse rate, blood pressure and respiratory rate was recorded. Oxygen saturation was measured by pulse oximeter. The patients were pre-oxygenated for three minutes and induction was done with thiopentone 4-5 mg/kg and fentanyl 1µg/kg, tracheal intubation was facilitated by suxamethonium 2 mg/kg and general anaesthesia was maintained by halothane 0.5%, N 2 0 60% and O 2 40%. Non-depolarizing muscle relaxant Inj vecuronium 0.1 mg/kg. was used for subsequent muscle relaxation. Intraoperative proper hydration was maintained with Lactated Ringers Solution. At the end of operation, residual effect of muscle relaxant reversed by Inj. Neostigmine 0.04 mg/kg plus Inj. Atropine 0.02 mg/kg. Analgesia was provided with per rectal diclofenac suppository (50mg) before extubation. The 24 hours study period was begin upon entry to the recovery room. The number and time of emetic episodes and the number & time of rescue antiemetic treatments will be recorded. The rescue protocol constituted of metoclopramide 10 mg injected once and repeated once if either nausea or vomiting continued for the next 10 minutes. Patients were carefully observed for any adverse effects like sedation, drowsiness, flushing or any extrapyramidal symptoms.
Statistical Analysis:
All data were complied and analyzed for statistical significance using unpaired student's t tests or Chi square tests. P<0.05 (CI 95%) were considered as statistically significant.
Results
Observations of the present study were analyzed in the light of comparisons among the subject groups (Group-A, Group-B; each group having n=25). All results are expressed as mean ± SD. The studied groups became statistically matched for age (p=0.458), weight (p=0.113), duration of surgery (p=0.907).
Variation of heart rate (beats/min) is displayed in Table- Sedation score after one hour post operatively varies from 0 to 2 for both the groups. In group-B, it was 0 for 80%, 1 for 12%, and 2 for 8% patients respectively, In group-A, it was 0 for 40%, 1 for 52% and 2 for 8% patients respectively and was statistically significant (p<0.05). The incidence of nausea was 24% in Group-B, 80% in Group-A (p=0.001) and vomiting was 16% in Group-B, 64% in Group-A (p=0.001). The difference among the groups was statistically significant.
There was no complication like flushing or any extrapyramidal symptoms in both the groups.
Discussion
Nausea and vomiting are common postoperative complaints and some times dangerous side effects following surgery under anaesthesia. Most of the incidents of nausea and vomiting occur during the first two hours of recovery from anaesthesia.
The aetiology of PONV is multifactorial. Factors associated with an increased risk of postoperative emesis include age, gender, obesity, previous history of motion sickness or postoperative vomiting, anxiety, gastroparesis, pain, hypoxia, type of anaesthetic, hypotension and type and duration of the surgical procedure. In the present study concern factors are type of anaesthesia, female patient and type of surgery (gynaecological laparoscopic surgery). Incidence of nausea and vomiting is two to three times more in female due to changing endocrine environment, which sensitize the brain stem emetic mechanism. During laparoscopic surgery the effect of pneumoperitonium as well as some traction of vagal innervated gut may play role in triggering emesis. So patients undergoing gynaecological laparoscopy assisted surgery are at high risk for postoperative nausea and vomiting.
The antiemetics are now mainstay of therapy to prevent nausea and vomiting. The introduction of 5-HT 3 receptor antagonist in 1990s was heralded as a major advance in the treatment of PONV because of less adverse effects that were observed with commonly used traditional antiemetic.
Malins et al. have also studied the efficacy of ondansetron compared with metoclopramide. 10 One hundred and fifty patients were given oral premedication 1 hour before gynaecological laparoscopy with ondansetron mg, metoclopramide 10mg or placebo. There was a significantly greater number of asymptomatic patients in the ondansetron group in the 48 hours after operation compared with the other two groups (74%, 58% and 50%, respectively (p<0.05). The average duration of anaesthesia was 21 minutes. The number of patients receiving rescue anti-emetic treatment was 38%, 57% and 68% respectively. There was no significant difference between the groups with respect to heart rate, systolic and diastolic blood pressure.
In our study, incidence of nausea and vomiting in group-A (those received ondansetron) were 24% and 16% and in group-B (Those received metoclopramide) were 80% and 64% that means asymptomatic patients in group-A is 76% in comparison to group-B is 20% (p=0.001). The average duration of anaesthesia was 30 minutes. In our study no patients received rescue anti-emetic treatment because there was no intractable vomiting (vomiting those occurred was 1 to 2 times only). Heart rate differences among the groups at base line (p=0.016) and postoperative period (p=0.009) was significant Systolic and diastolic blood pressure differences among the groups were not significant (p<0.05).
The difference in the results of asymptomatic patients in our study 20% compared with those of Malins et al. 58%, may be explained by; a small number of population and the mean duration of anaesthesia was greater in our study. Heart rate variation among the groups at base line and in post operative period were significant, may be explained by, a small number of patients.
Sedation score after one hour post operatively varies from 0 to 2 for both the groups. In group-A, it was 0 for 80%, 1 for 12%, and 2 for 8% patients respectively, In group-B, it was 0 for 40%, 1 for 52% and 2 for 8% patient respectively and was statistically significant (p<0.05). It may be explained that patients of Group-B was more sedated.
Conclusion
Under the condition of the present study we found that oral premedication with ondansetron 8 mg is more effective and produce fewer side effects than metoclopramide 10 mg in preventing postoperative nausea and vomiting after laparoscopy assisted gynaecological diagnostic procedure.
